Healthy volunteers (n = 32) | COVID-19 patients (n = 73) | |
---|---|---|
Age (years) | 34 ± 10 | 59 ± 13* |
Gender (male), n (%) | 16 (50) | 51 (70)* |
BMI | 23 ± 3 | 30 ± 5* |
Days from hospitalization (n) | – | 5 ± 4 |
Days from IRCU/ICU admission (n) | – | 3 ± 3 |
APACHE II score | – | 14 ± 8 |
Pre-existing comorbidities (n, %) | ||
Hypertension | – | 33 (45) |
Diabetes mellitus | – | 17 (23) |
Smoker | – | 18 (25) |
COPD | – | 7 (10) |
Temperature (°C) | 36.3 ± 0.3 | 36.0 ± 0.7 |
HR (beats/min) | 75 ± 13 | 77 ± 16 |
MAP (mmHg) | 83 ± 9 | 86 ± 12 |
RR (resp/min) | 18 ± 3 | 22 ± 5* |
SpO2 (%) | 97 ± 2 | 95 ± 4 |
FiO2 (%) | 21 ± 0 | 54 ± 21* |
StO2 (%) | 65 ± 3 | 67 ± 6 |
THC (μM/L) | 45 ± 11 | 43 ± 16 |
DeO2 (%/min) | − 9.1 ± 2.4 | − 5.2 ± 2.0* |
ReO2 (%/min) | 120 ± 55 | 77 ± 37* |
Hyperemia AUC (U) | 14.8 ± 6.8 | 8.5 ± 5.0* |